The p16/INK4A protein is a cellular regulatory polypeptide over-expressed in the presence of high levels of the Human Papillomavirus (HPV) coded E7 protein. This review outlines the use of p16 antigen staining in cervical biopsies as well as in PAP smears summarizing the corresponding literature and commenting the authors' own experience. The p16 antigen is a reliable marker for dysplastic cells in CINII/CINIII (HSIL) lesions as viewed in cervical biopsies. When PAP smears were examined at large scale screening for p16 antigenreactive and atypical cells, considerable variations could be found especially in ASCUS graded lesions. Therefore, the presence of p16-reactive atypical cells in PAP smears should be interpreted together with the cytological signs of dysplasia, such as the altered N/C ratio. In addition, women revealing p16-positive ASCUS/LSIL specimens should be examined for the presence of HPV DNA. Detection of HPV DNA alone, i.e. in the absence of cytological screening has a low predictive value, since the clearance of HPV may occur even in the absence of morphological alterations. Combined cytological as well as molecular follow up contributes to the efficiency of diagnostic and increases the probability of correct interpretation of the pre-cancerous lesions by non-invasive techniques.
Abbreviations

Host cell transformation by human papillomaviruses
Human papillomaviruses (HPV) infecting the female genital tract represent the main cause of cervical dysplasias [1, 2] and subsequently developing squamous cell carcinomas (SSC). In addition to HPV, the Papillomaviridae family encompasses viruses infecting cattle (BPV), monkeys (RhPV), horses (EcPV) and other mammals. The human (HPV) isolates were grouped into 118 genotypes based on the similarity and/or variations of their genomes. The genotype was defined by at least 10% dissimilarity of the capsid polypeptide (L1) sequence. Based on the comparison of L1 sequences of all genotypes, 96 of them fulfilling the above mentioned criterion were included into the novel classification, while the rest are regarded either for candidate genotypes and/or for subtypes (2-10% nucleotide dissimilarity). According to novel classification [3, 4] , the Papillomaviridae family has 13 genera. The clinically important genotypes that cause lesions at mucosal membranes and/or on the skin belong to 12 out of 15 species within the Alphapapillomavirus genus (Table 1) . Noteworthy, the recently accepted L1 phylogenetic tree-based classification may not reflect the serological relationships among the L1 proteins.
No Alphapapillomavirus common or species-specific epitopes could be determined in cross ELISA tests against recombinant L1 fusion proteins from 15 HPV genotypes representing 6 species [5] . In clinical practice, the genotypes most probably associated with cancer and/or with severe dysplastic changes, were designated as high risk (HR-HPV). In contrast, genotypes causing benign lesions and only exceptionally related to cancer were designated as low risk. The HPV virions are small (55 nm in size) nonenveloped capsids. As result of productive replication, they form aggregates within nuclei of squamous epithelium cells that show koilocytosis [6] . HPV does not grow outside of squamous epithelium cells, i.e. it is extremely difficult to isolate the virus in conventional human cell cultures [7] . The purified virions reveal icosaedral symmetry, being composed of 72 subunits formed by 2 structural proteins (L1 and L2), which are expressed at late intervals of the productive replication cycle. The viral double stranded DNA (vDNA) has about 8 kilobase pairs (kbp) and encodes 7 or 8 nonstructural polypeptides, designated E1-E8 (E=early). The transcription of viral mRNA is under control of a 1.1 kbp vDNA region, which is rich in promoters (LCR=long control region). The oncogenic virus coded polypeptides E5, E6 and E7 induce cell proliferation and/ or may drive cells into permanent division by different mechanisms. Their open reading frames (ORF) are located close to LCR, which has a great impact for host cell transformation resulting from the integration of HPV genome in the course of latency [8] [9] [10] [11] . Because the HPV genome does not encode its own DNA polymerase, its productive replication depends on the division of host epithelium cells. The vDNA molecules are copied by the help of E1 and E2 proteins within dividing cells of the basal and/or suprabasal layers of squamous epithelium.
Disease
Frequent association Rare association
Skin infection:
Deep plantar warts 1, 2 4, 63 During differentiation of the stratified epithelium, productive (vegetative) virus replication continues within the spinous and/or surface epithelium cells, in which the L1/L2 and E4 proteins are abundantly expressed ( Table 2 ). The E4 protein causes dramatic changes in the cytokeratin network altering the cytoplasmic environment of spinous cells, which contributes to the HPV induced cytopathic effect and koilocytosis [12] [13] [14] . These changes accelerate the release of virions assembled due to self-aggregation of the L1/L2 protein complexes. In contrast, the few vDNA copies harbored in suprabasal and transitory cells during latency get distributed into dividing daughter cells by means of E2 protein [15, 16] . In such a way, the latent HPV genome is continuously maintained in the basal and suprabasal squamous epithelium layer despite the absence of productive virus formation. It should be mentioned that during long-term latency, the integration of HPV DNA may associate with linearization of the persisting vDNA molecule. At integration, the circular HPV DNA is interrupted, usually within the E2 gene ORF [17] . Thus, the HPV genome persists within transformed host cells in two different forms: as non-integrated (episomal) circularized full-length vDNA and, less frequently, as a linear and integrated vDNA sequence with the E2 ORF partially deleted (preferentially at nt 3362-3443) [18, 19] . The mixed (episomal as well as integrated) vDNA distribution pattern seems the most prevalent physical state of HPV16 DNA found in ASCUS graded smears (atypical cells of unknown significance), but can also be detected in cervical scrapings still not revealing pathological changes. This indicates that HPV infection may not always cause dysplasia of the squamous epithelium cells. The prevalence of the integrated HPV DNA sequence over episomal molecules then appears in a proportion of ASCUS graded smears (sometimes characterized by ASC-H cells) and in LSIL smears, but later on becomes clearly prevalent in HSIL grade smears and, of course, in cervical cancer. Women showing the prevalence of integrated HPV DNA were almost 10 years older than those with a predominating episomal HPV DNA pattern, which points to a higher risk of HPV infection in women aged over 35 years [20] . Three non-structural HPV coded oncoproteins are involved in host cell proliferation and immortalization (E5, E6 and E7) causing continuous host cell division rather than direct malignant transformation ( Table 3) . The E5 protein enhances the sensitivity of HPV carrier cells to external proliferative stimuli, such as the epidermal growth factor [21] . It also binds to growth factor receptors, for example the platelet growth factor receptor (PDGFR), and activates the signal transmission in a ligand independent manner [22, 23] . Because the integrated vDNA always encompasses the ORFs of E6 and E7 oncoproteins as well as the closely positioned LCR sequence, the continuing and increased expression of E6/E7 proteins seriously affects the regulation of host cell division [24, 25] . Noteworthy, E6 polypeptide interacts with the pivotal cell division inhibiting p53 protein [26] , while the E7 polypeptide binds the retinoblastoma (Rb) protein and cyclin inhibitory proteins p27 and p21 [27] . The HPV coded oncoproteins E6/E7, when present in significant amounts, continuously drive host cells from phase G1 to phase S. Noteworthy, the process of cancerogenesis is more complex and may be related, for example, to increased number of c-myc gene copies in HPV DNA transformed cells, a phenomenon proportional to the grade of dysplasia seen in the corresponding lesion [28] . The aim of this paper is to consider the role of p16/ 
Overexpression of the p16/INK4A polypeptide in HPV transformed cells
The p16/INK4A (inhibitor kinase) polypeptide is a cellular regulatory protein, which inhibits the cyclin dependent kinases (especially cdk4 and cdk6) associated with cyclin D. As shown in Figure 1 , the activated kinases (cdk4 and/or cdk6) phosphorylate the retinoblastoma phosphoprotein (pRb) complex, which in turn, releases the transcription factor E2F, which in the non-dividing cells is bound in its inactive form. Under physiological conditions, the free Rb protein liberated from the disrupted complex has a feedback effect on p16 expression [29] . Since the E2 polypeptide binds to LCR (Table 3) , the presence of E2 in cells carrying the episomal HPV DNA may efficiently control the transcription of mRNA encoding the E6/E7 oncoproteins [30] . In contrast, the cells carrying an integrated HPV genome would stop producing the E2 polypeptide due to disruption of the E2 ORF. Therefore, E2 but also E1 proteins (both are closely related to the maintenance of long term latency) may be missing in HPV transformed cells, which eliminates the down regulation of E6/E7 oncoprotein production. Taken together, in HPV transformed cells, the expression of p16/INK4A protein increases proportionally to elevated levels of the virus coded E7 polypeptide, since both arise in the absence of E2 [31] [32] [33] [34] . The histopathology of precancerous cervical squamous intraepithelial lesions (SIL) has been thoroughly reviewed [35] . The mild forms are usually referred to as low grade SIL (LSIL), whereas the progressed forms are referred to as high grade SIL (HSIL). The SIL classification had been originally introduced for vaginal/cervical smears [36] , but later on it became widely known as the Bethesda system and adopted for histological scoring [37] . However, long before introduction of the latter scoring system, pathologists developed their own nomenclature, Binds to retinoblastoma (Rb) protein and the functionally related p107 and 130 proteins, which regulate cellular transcription ( Figure 1) . Binds to the signaling protein c-Jun and inhibits the expression of cyclin dependent kinases. Activates cyclins A and E and the transcription factor AP1. Activates the histone deacetylase (HDAC) and increases cellular transcription cyclin D (cell division regulator) and phosphorylate the retinoblastoma phosphoprotein (pRb). The phosphorylated pRb becomes activated (ppRb) and releases the transcription factor transcription activator E2F, which in turn, is transported to nucleus. Under physiologic conditions, the p16/INK4 polypeptide (which is an inhibitory kinase) inhibits cdk4/6 activity. The high level of free ppRb has a feedback effect on INK4/p16 synthesis. Because the E7 oncoprotein binds the pRb protein in dysplastic and/or HPV-transformed cells, the availability of the latter decreases in them, while the expression of p16 increases.
which is until now frequently used for cervical biopsy grading. In this system, the precancerous changes of exocervical squamous epithelium are designated as cervical intraepithelial neoplasia (CIN). The changes at CIN are associated with the appearance of altered (dysplastic) cells still showing a diploid nuclear pattern [38] . Therefore, the CIN I stage cannot be regarded as truly neoplastic. Dysplastic cells are characterized by loss of polarity, crowding, overlapping, disorganization and anisocytosis. At the cytological level, the dysplastic cells show altered nuclear to cytoplasm (N/C) ratio as well as wrinkling and thickening of nuclear membrane. For reasons discussed below, it seems useful to group any CIN I grade changes into the entity of LSIL [39] . In mild forms designated CIN I/LSIL, the dysplastic cells as a rule, occupy the parabasal epithelium layer.
Being located in the lower third of cervical squamous epithelium, dysplastic cells form a continuous zone easily distinguishable by p16 antigen staining ( Figure 2 ). Table 4 shows that parabasal staining of p16 antigen in mild grade CIN I/LSIL dysplasia might be positive in up to 81% of specimens. This result probably represents the highest limit as compared to the findings of others. Intensive parabasal staining for p16 antigen was described in not more than 47% of CIN I cases, but continuous positive staining of lower intensity was reported in over 70% of CIN I cases [40, 41] . Summing up the results of antigen p16 staining in the biopsy sections graded CIN I/LSIL, Yildiz et al. [42] recognized continuous parabasal staining of high intensity, continuous parabasal staining of lower intensity and scattered staining of dispersed squamous epithelium cells. The latter pattern of p16 reactivity ( Figure 3 ) cannot be regarded for an indicator of dysplasia, since it shows p16 positive spinous cells at non-typical localization. Scattered distribution of p16 expressing cells points at their transient proliferation rather than at the association with HPV latency and E7 overproduction. If dysplastic cells occupy at least one half (or two thirds) of the original squamous epithelium (but not the whole epithelial layer), the appropriate designation is CIN II. In CIN II/HSIL, the p16 staining may be helpful for defining the precise thickness of dysplastic changes (Figure 4 ). At the stage of CIN III/HSIL, dysplastic cells replace the original epithelium in full, so that the p16 staining becomes diffuse ( Figures 5, 6 ). In both, CIN II as well as CIN III, the p16 reactivity is a helpful indicator of the extent of dysplasia. As reported [43] , medium (CIN II) and/or severe (CIN III) dysplasia was accompanied with the presence of p16 antigen at 95% (in 45 out of 47) and/or at 100% (in each of 27) of specimens, respectively (Table 4 ). In CIN III/HSIL, intensive staining of p16 antigen can be seen within nuclei as well as the (Figure 8 ). Though the p16 staining is a useful marker for dysplastic squamous cells and/or spinous carcinomas, it may be of reduced sensitivity for the detection of glandular dysplasias and/ or endocervical carcinomas originating from cylindrical epithelium cells [44] . Along with the discovery of vaginal HPV infection, the term condyloma acuminatum was introduced to describe the predominantly benign vaginal/cervical lesions characterized by viral cytopathic changes (koilocytes) and/or hyperplasia of the basal and parabasal epithelium cells [45] [46] [47] . Nevertheless, it has turned out that it is impossible to differentiate, using classical histology, between mild cervical lesions caused by LR-HPV types (such as HPV 6 or 11) and/or the early stages in the lesions caused by HR-HPV [48] . Many early HPV-related CIN I/LSIL lesions of the stratified epithelium include mild nuclear atypia associated with extensive perinuclear "halo" and cytoplasmic cavitation (koilocytosis). These changes occur at the spinous and surface layers along with the mild dysplasia and/ or hyperplasia of basal and suprabasal layers. In such cases, p16 staining helps to recognize dysplastic cells located within the parabasal layer from the p16 negative koliocytes in the medium and/or upper spinous layers undergoing cavitation and vacuolization ( Figure 9 ). Noteworthy, in situ hybridization shows the presence of abundant HPV DNA predominantly in the nuclei of productively infected p16 negative koilocytes, even though dysplastic cells as well as cancer cells also are vDNA positive [49] . The positive rate of HPV 16 genome presence as detected by the less sensitive in situ hybridization technique increased from mild to severe dysplasias reaching just about 50% in CIN III/HSIL.
(i.e. over the course of many years), depending on the extent of vDNA integration (which is higher in HR-HPV infection), disruption of E2 gene and loss of E2 protein production along with additional cofactors facilitate continuous division of carrier cells (immortalization) resulting in the development of carcinoma.
Immunohistochemical detection of p16 antigen in dysplastic cervical cells and/or in cervical carcinoma cells is less tedious than that of E7 protein and/or mRNA [54] . Despite the high statistical relevance of p16 detection in bioptic materials graded as HSIL, at the stage of LSIL some pitfalls may hamper the distinction between reactive (proliferative) changes and the initial dysplastic lesions. As already mentioned, an increased p16 expression unrelated HPV infection may occur in single epithelium cells for reasons other than E7 over expression. The expression of CDKN2A gene (encoding p16 protein) due to proliferative stimuli is activated by alternative pathways. As shown in Figure 3 , dispersed non dysplastic spinous epithelium cells as well as proliferating fibroblasts below the epithelium layer may occasionally express p16 protein to the extent that they are rendered stainable with the commercially available monoclonal antibody (CINTec histology kit). Tissue fixation, variations in pre-and post-staining procedures, differences in the antibody reactivity and dilution would also influence the staining results, especially in CIN I/ LSIL cases which show faint p16 reactivity.
A frequently used immunohistochemical marker in intraepithelial cervical dysplasia (CIN/SIL) is the Ki-67 protein that occurs in the nuclei of proliferating and/ or repeatedly dividing (immortalized) cells, including dysplastic cells [55] . The decreased availability of the functioning Rb protein due to the over-expression of E7 polypeptide, not only leads to p16 overexpression, but also explains the higher expression Ki-67 protein [56] . To achieve precise grading of LSIL versus HSIL lesions following Ki-67 antigen staining, Kruse et al. [57] suggested to count the number of positive nuclei per 100 μm epithelium thickness starting from the parabasal zone (stratification index). The authors in question found a positive correlation (of 83%) with the original histological classification based on H.E. staining, but also noticed a tendency to worse grading at the primary evaluation of the H.E. staining results. Namely, in two cases (3%) Ki-67 staining showed lesions grade CIN I rather than lesions grade CIN II as described in H.E. stained sections. In nine cases (14%), the original diagnosis for H.E. stained sections was CIN III, but the Ki-67 staining based score was CIN II. A similar tendency to worse grading if evaluating the H.E. stained sections only, i.e. not regarding to p16 staining, is noted in Table 5 . According to this experience, the Because the early HPV-related CIN I/LSIL grade lesions do not represent true neoplasia, but reactive changes and/or beginning of immortalization due to HPV infection, several authors prefer the SIL terminology. In fact, only a small proportion of CIN I cases progresses quickly to grade CIN II and/or CIN III [50] . The CIN I/ LSIL state frequently develops into subacute but still transient HPV infection, which heals spontaneously with a probability of about 60% [51] . In association with the accumulation of HPV virion-specific T lymphocytes below the epithelium layer, many koilocytes undergo apoptosis. The T cell lymphoproliferative response is specific for E6/E7 antigens and accelerates the HPV 16 clearance [52] . As noted by others, 67% of the HR-HPV positive cases may show regression of LSIL lesions and clears without transition to HSIL. If the virus persists for at least 12 months in the non-productive (latent) state, the probability of progression to CIN II/CIN III within next 18 months, i.e. by 30 months of the observation period, has increased to about 23% [53] . Even when the virus-producing squamous cells are slowly eliminated, the episomal full length vDNA still persists for a long time. During non-productive latency, the virus carrier cells double at each division and vDNA gets copied and redistributed into daughter cells. The expression of E1/ E2 polypeptides continues at moderate levels, while the intensity of E7 expression still remains low. Later on [58, 59] . Similarly to p16 antigen detection, the Ki-67 protein also shows non-specific expression in proliferating cells in at least in 10% of cases [60] . The zonal distribution of p16 reactivity fits better with the classical grading into CIN I (dysplasia encompasses less than one third of stratified epithelium), CIN II (dysplastic cells encompassing more the half or up to two thirds of squamous epithelium) and CIN III (nearly diffuse distribution of dysplastic cells encompassing the whole epithelium). Therefore, staining of p16 antigen has recently emerged as a preferred diagnostic marker suitable for quick demonstration of the extent of dysplasia.
Geisinger et al. [62] , the main criterion for the clear definition of SIL is an increased size of nucleus (<3 fold for ASCUS, > 3 fold in LSIL), increased intensity of chromatin staining and its altered internal structure (finely granular chromatin structure and slight hyperchromasia in ASCUS, coarse chromatin and definitely visible hyperchromasia in LSIL and/or HSIL). The diagnosis ASC gains prediction value, only if based on the presence of a few HSIL-like cells (so called ASC-H), pointing at progression to LSIL and/or HSIL from early beginning. Nevertheless, the ASC-H category seems problematic, since the morphologic difference in the appearance of a single metaplastic and/or neoplastic cell is not always clear and opens the way to false positive as well as false negative diagnoses [63] [64] [65] . Abati et al. [66] stressed that nuclear hyperchromasia and irregular nuclear membrane contours count for the most reliable diagnostic feature of so-called pre-neoplastic atypia (possibly corresponding to the dysplastic cells in histological sections). In most uncertain cases, a short course of local estrogen cream therapy followed by repeated PAP tests was suggested as helpful [67] . More recently, improved cytological tests were introduced, such as liquid based cytology (Liqui-PREP), which resulted in a significant decrease of unsatisfactory smears and detected more atypical squamous cells and LSIL lesions due to enhanced cell visualization in comparison with conventional PAP smears [68] . Several reports claimed the relative value of p16 staining in ASCUS smears, which may be positive in 60% of cases, a finding designated p16 reactive ASC. The proportion of p16 negative smears is usually the highest in ASCUS (40%) and the lowest in HSIL (5%) specimens [69, 70] . According to Shin et al. [71] , p16 antigen was found in 66.7% of ASCUS and 70% of LSIL cases, confirming that detection of p16/INK4 protein can be used as adjunct test especially at liquid-based cytology. However, several authors noticed a high degree of false p16 reactivity within otherwise negative smears, especially in those containing atrophic cells [72] . The latter authors stressed that in such smears the number of p16 reactive atypical cells per total cell number of cells may not represent a significant feature. This situation is unlikely for biopsy sections, where the confluent distribution of p16 positive cells within the parabasal layer is essential for interpretation of the staining result. In smears the most important scoring criterion for each particular p16 reactive cell still remains the evaluation of nuclear changes, such as the altered N/C ratio. According to our experience, a relatively high percentage of p16 reactive atypical cells could be found not only in LSIL, but also in smears classified as ASCUS, if specimens were scored regardless 
* full agreement found in HSIL cases (per cent) ** number of HSIL from total SIL
The diagnostic significance of p16 staining of cervical smears in comparison with HPV DNA testing will be discussed below. Here, the morphological criteria for ASC (atypical squamous cells) will be mentioned versus reactive squamous cell proliferation (no dysplastic epithelium cells as in LSIL and/or HSIL cases). The Bethesda Committee (1991) definitions and classification were later improved and widely accepted [61] . Comparisons among laboratories showed that the diagnosis of ASC-US (atypical squamous cells of undetermined significance) should not exceed 5-6% of the total number of smears investigated. As stressed by of the presence or absence of HPV DNA (Table 6 ). There was little difference between the p16 reactivity of atypical cells either in ASCUS and/or LSIL smears coming from women, in which the HPV DNA test was positive (Table 7, Figure 10 ). In the ASCUS smears from women that were negative for HR HPV DNA in the HC-2 test, the p16 reactive atypical cells still comprised a considerable proportion of investigated specimens, even though the use of a suitable staining kit reduced the number of false positive antigen-reactive cells (Table 8) . Namely a significantly lower positive rate for p16 was noted in ASCUS smears, if the staining procedure was performed with the CYNTec cytology kit (only about 40% of the tested smears showed p16 reactive cells, Table 6 ). Our results with a relatively modest number of patients with DNA positive as well as p16 antigen positive smears showed that p16 staining of atypical squamous cells might be a helpful diagnostic tool in the ASCUS/LSIL cases. If the patients were not tested for HPV DNA presence, the p16 positive atypical cells in LSIL graded smears are more easily found as compared to the classical staining only (Figures 11  and 12 ). On the other hand, it became clear that p16 reactive cells may be seen in the smears from HPV negative patients, which were graded ASCUS and/ or LSIL ( Figure 13) . As shown by the analysis of DNA negative smears (Table 8) , a relatively large proportion of false positive p16 reactive cells (about 37%) could be still seen even when the ASCUS smears were stained with the CYNTec histology kit. Therefore, we stress the need to test the alternatively taken specimens for HR-HPV DNA during the ASCUS/LSIL follow up. To avoid confusing results of p16 staining especially in the ASCUS smears (depending on the kit used) and due to spontaneous healing of the HPV unrelated lesions, it seems reasonable to interpret the available PAP and/or p16 stained cytology along with the results of the HPV DNA test. conserved regions located either on L1 and/or E1 ORFs, enabling detection of a wide spectrum of genotypes [75] . In resulted that the GPs annealed not only to ORFs for which they had been designed, but also to some ORFs for which genotypes had not been sequenced at that time (later on identified as HPV 13, 30, 31, 45 and 51). The consensus or general primer GP5+/ GP6+ based procedure became widely used, since it enabled the differentiation between several HR and LR HPV genotypes in a single assay [76, 77] . Originally, the bands were visualized by Southern blot hybridization. The GP-PCR technique became further improved in order to detect more genotypes (at least 14 HR HPV along with the 6 frequent LR HPV genotypes). In addition it was modified to visualize the reaction product by IEA [78] . For latter purposes, one of the primers was biotinylated and the amplified mix was captured to the wall of streptavidin-coated microwells. After incubation of micro-wells with the amplified product, following washing and denaturing, a hybridization cocktail of digoxigenin-labeled internal oligonucleotide probes was 
HPV DNA detection as compared to the scoring of morphological lesions
Since HPV is extremely difficult to culture [7] , the most feasible diagnostic approach is to prove the presence of HPV DNA by molecular techniques. In general, these are based on DNA/DNA hybridization (using labeled complementary DNA probes), on amplification of vDNA by polymerase chain reaction (PCR) and/or on DNA/ RNA hybridization (using complementary RNA probes) followed by the amplification of labeled hybrid signal. Early approaches utilized various modifications of the vDNA to DNA probe hybridization tests, such as in situ hybridization and/or various blotting techniques [73] . To improve the PCR method, multiple primers for L1 and/ or E1 gene amplifications have been introduced, aiming to amplify the most frequent genotypes (i.e. HPV 6, 11, 16 and 18) in a single tube reaction [74] . The principle of multiple genotype amplification was further modified by using general primers (GPs), which flank the strongly added to the wells in order to detect the bound hybrid using immunohistochemical reagents. [81] . To avoid the methodic variations, automated vDNA extraction was recommended for HPV genotyping for both, the classical PCR (GP5/GP6 primers) as well as for the real time PCR based quantitative TaqMan assay. An agreement was found when comparing both techniques in nearly 300 specimens [82] . Further modification of HPV detection in the direction of immunochemistry has resulted into an assay omitting vDNA amplification, while introducing signal amplification instead. In a latter assay, the denatured vDNA was hybridized under high stringency conditions to single stranded RNA probes either for LR genotypes (at least 6, 11, 42, 43 and 44) and/or for HR genotypes (at least 16, 18, 31, 33, 35, 45, 51, 52 and 56) . The RNA/DNA hybrid complex was then bound to microwells (or tubes) coated with an alkaline phosphatase conjugated monoclonal antibody, able to capture the specific RNA/DNA hybrid [83] . The reaction is then visualized by addition of the chemilumiscent substrate, in which emission light is amplified and measured in a luminometer; the results are expressed in relative light units (RLU). This method is referred to as hybrid capture (HC). At its beginning HC showed lower sensitivity, since only 50.000 vDNA copies could be detected as compared to as few as 10-100 vDNA copies (about 100 fg HPV DNA) detectable by the more sensitive PCR. Recio et al. [84] used the first generation HC test for investigating the HPV DNA presence in patients with ASCUS, LSIL, HSIL and carcinoma in situ smears, the latter being used as relevant standard. Altogether 44% of patients were tested positive, mainly for HR HPV genotypes. The combination of LSIL/HSIL cytology and HPV HC testing increased the sensitivity but not the predictive value of screening in the moderate as well as severe dysplasias to 77.7% and 96% respectively. The authors concluded that testing of HPV DNA by HC method is helpful for clinical diagnoses. Later on, the HC test was improved by introducing a second generation HC protocol improving both the sensitivity as well as the spectrum of RNA probes [85] . The recent HC2 based HPV DNA test (Digene), which is used in our laboratory, detects at least 14 HR genotypes (HPV 16, 18, 31, 33, 35, 35, 39, 45, 51, 52, 56, 58 and 68) at a sensitivity of 1-2 pg/ml (i.e. 1000 HPV DNA copies). This assay can be also used for detection of at least 5 LR genotypes (HPV 6, 11, 42, 43 and 44) .
The HC2 test was found nearly as sensitive as the GP5+/GP6+ primer directed PCR/EIA test. When HPV DNA samples were collected for histological diagnosis of severe dysplasia (CINII/CINIII/HSIL) before conization and/or loop diathermy as well as 4 to 9 months afterwards, a satisfactorily high substantial agreement for both tests was noted, i.e. k=0.70 before and k=0.72 after the treatment. This suggests that both tests are almost equal [86] . When in cervical smears the approved HC2 test and the nested PCR utilizing the MY/GP primers have been compared, some authors found a higher sensitivity (96.6% versus 58.6%) in favor of the HC2 test [87] . Either the HC2 (Digene) test or the commercial PCR test were recommended in addition to cytological testing in order to enhance the probability of precise assessment as well as to increase the screening efficiency among the clinically healthy (symptomless) patients enrolled for screening [88] . Under the conditions of Saudi Arabia, the HC2 detected HR HPV in 5 and LR-HPV in 1 patient only (6% of the total volunteers tested), while PCR detected vDNA in 4 patients (4% of the total tested). When 148 patients with mild dyskaryosis in their Pap smears (ASCUS/LSIL) were enrolled for HPV detection by the HC2 test and by two modifications of the PCR test (either PGMY09/PGMY011 primers and/or CPI/CPIIG primers), the HR-HPV by HC2 test was detected in 32 out of 38 samples positive in either alternative test (25.6% out of the total tested). The letter percentage reflects how many patients were positive for at least one HPV DNA test, since HC2 results can remain negative in cases of double infection and/or in cases of infection with unusual genotypes such as HPV 44, 53, 68 and 73 types detectable by the PCR based tests only [89] . Mo et al. [90] reported that the HC2 test as compared in 470 patients with the PCR-based Roche Amplicor HPV test, reached and agreement of 96.2%; only 18 cases were found discordant. It should be mentioned that the Amplicor HPV test identifies the PCR amplified vDNA by means of 13 HR-HPV genotype probes, and that the [92] . The authors in question claimed that the HC2 and the Amplicor kit results had been most closely related and that a complete agreement (positive in all tests) could be found in 75% of the specimens. They tried to explain these disagreements by the relatively small virus load within the cervical fluids of chosen patients.
The predictive value of combined HPV DNA and PAP smear testing and the development of cervical carcinoma
A large cohort of woman (about 25,000) with negative PAP smears (Thin-Prep imaging system) was enrolled for HPV DNA testing over a period of 2 years [93] . The highest proportion of HPV positives (average positive rate 1.9%) was found in women younger than 30 years and then sharply declined (from 2.8% to 1.7%). These data confirm the great diagnostic value of follow up by PAP screening, even when the HPV DNA test had been done first. The New Technologies for Cervical Cancer Screening Study [94] compared the results of repeated screening with liquid-based cytology alone and the combined screening with the HC2 test (with the sensitivity of 1-2 pg/ml) and by cytology in a similarly large group of nearly 25.000 women. Those younger than 35 years were retested within 1 year. Repeated testing showed that among women aged 25-34 years the informative value of combined HPV and cytology was higher, since there was a frequent regression of even grade CIN II dysplasia developed in HPV positive women. In the age group over 35 years, there was a substantial gain for the informative value of HPV testing (when using a cut off value of 2 pg/ml) as compared with cytology, since the probability of spontaneous regression was lower in the latter age group. In any case, a combined and/or repeated cytology testing is needed, if the HPV DNA is tested first. On the other hand, any HPV DNA test in women showing ASCUS/ LSIL smears was clinically useful [95] . As shown in over 4000 women, both the PAP cytology testing as well as the HPV DNA test (regardless of kind used) were negative in 65% of subjects. Normal cytology, but positive (at least one) DNA tests were found in 17% of patients. A similar proportion of women had positive ASCUS/LSIL cytology (18%). The ASCUS/LSIL positive women when tested for HPV DNA fell into two groups, namely those which were positive by at least one DNA test (9%) and those who were DNA negative (9% [98] . Also in this follow up, a relatively low proportion (6.7%) of ASCUS positive patients developed HSIL or cancer. Among the patients with HSIL smears, up to 98% was found HPV DNA positive; theoretically such women harbor the integrated incomplete genome in the cervical tissue. In the study in question, it was concluded that the residual specimens collected from routine cervical cytology in ASCUS cases, could provide additional information about the HPV DNA status that is of substantial help in identifying those patients, who are likely to develop HSIL, if they later test positive for HPV DNA. The aim of this paper was to confirm whether p16/ INK4a antigen staining is a biomarker for transforming HPV infections that could act as an adjunct to current cytological and histological assessment of cervical smears and biopsies. In addition to above presented considerations, most recent reports conclude that p16/INK4A seems to be a sensitive biomarker of the high grade cervical intraepithelial neoplasia and cancer, especially in cervical biopsies [99] . According to our results, which are in agreement with others, p16 staining of cervical smears may show uncertain results, since false positive reactivity of the atypical squamous cells concerns about 20-25% of ASCUS smears and depends on the kit used. Although there is good evidence that p16/INK4A immunostaining correlates with the severity of cytological/histological abnormalities, the reproducibility is limited also due to insufficiently standardized interpretation of p16 staining results [100] . In future, a better consensus should to be reached for evaluation and interpretation of the p16/INK4a antigen stain in cervical smears. The presence of p16 antigen in dysplastic versus atypical squamaous cells needs to be assessed regarding the various clinical and morphological settings, each addressing specific diagnostic questions. The authors of this review are convinced that satisfactory consensus was already achieved for the evaluation of histological lesions in biopsy material. The assessment of p16 staining results within the cell smears waits for additional large-scale studies.
Conclusions
Overwhelming literature (over 2000 reports) confirmed the strong association between HR-HPV infection and the development of the precancerous lesions of cervical epithelium (such as CINIII/HSIL, in situ carcinoma) and their transition into cervical carcinoma. Out of various screening approaches, most effective and less expensive is the cytological examination. Classical PAP staining has been improved by introducing thin layer liquid cytology and by application of immunohistochemistry, especially p16/INK4A antigen staining. However, the detection of p16 antigen showed reliable results in histological sections only. In contrast, a great proportion (about 20-30%) of p16 antigen stained smears which were graded ASCUS/LSIL, may yield uncertain results. Therefore, the best strategy is to test for HPV DNA in all women revealing ASCUS/LSIL graded smears, which stained positive for p16 antigen. Several authors recommend concomitant examination by HPV DNA test of the rest of cells submitted for smear preparation and/or repeated sampling for HSV DNA within a short interval thereafter (but not later than 4-6 months). The result of the HPV DNA test alone and/or if this test is completed first, has a relatively low predictive value, especially in women younger than 30-35 years, since a large proportion of HPV-positive cases may become DNA negative. If the HPV DNA is not cleared within 6-12 months following the first DNA test, preparation of the PAP smear along with p16 antigen staining is strongly recommended. The assessment of morphological status along with the clinical signs is essential for further therapy and/or for the decision of biopsy examination. The combined approach, i.e. cytology as well HPV DNA testing can effectively assess the current state and predict the probability of transition to HSIL/CINIII grade dysplasia helping to avoid unnecessary radicalism in the case of false positive diagnosis.
